Overview
- Drug Interactions Among Antiretrovirals and Other Drugs: NNRTIs (PDF) (January 29, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents. For the full guidelines, click here (PDF).
From AIDSinfo
- Drug Interactions Among Antiretrovirals and Other Drugs: NRTIs (PDF) (January 29, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents. For the full guidelines, click here (PDF).
From AIDSinfo
- Drug Interactions Among Antiretrovirals and Other Drugs: PIs and Maraviroc (PDF) (January 29, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents. For the full guidelines, click here (PDF).
From AIDSinfo
- Drugs That Should Not Be Used With PI, NNRTI , or CCR5 Antagonist Antiretrovirals (PDF) (January 29, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents. For the full guidelines, click here (PDF).
From AIDSinfo
- Dosage Adjustments for ARV-ARV Drug Interactions (Adult Dosing) (July 2006)
From AIDS Education & Training Centers National Resource Center
- Antiretroviral Medications and Oral Contraceptive Agents (2006)
A chapter from Clinical Manual for Management of the HIV-Infected Adult.
From AIDS Education & Training Centers National Resource Center
- Drug Interactions and Anti-HIV Therapy (Summer 2005)
To read PDF, click here
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- A Review of Interactions Between Natural Health Products and HIV Medications (April 2005)
A brief summary of a report in the International Journal of STD & AIDS.
From The Body PRO
- Psychiatric and HIV Medication Interactions (January 2005)
A chart outlining known interactions between psychiatric medications and NRTIs, NNRTIs and protease inhibitors.
To read PDF, click here
In Infectious Diseases in Corrections Report, from Brown Medical School
- Drug Interactions Fact Sheet (August 2004)
An exhaustive list of drug interactions.
To read PDF, click here
From Project Inform
- Case Study: Drug-Drug Interactions Associated With the Use of Antiretroviral Therapy (March 2004)
In HEPP Report, from Brown Medical School
- Clinically Significant Drug Interactions Associated With Highly Active Antiretroviral Therapy (January 2004)
To read PDF, click here
In HEPP Report, from Brown Medical School
- Risky Cocktails (April 2003)
A chart of interactions between alcohol/recreational drugs and HIV antiretrovirals.
In Survival News, from AIDS Survival Project
- Methadone and HIV Medications: Drug Interactions (Winter 2002/2003)
To read PDF, click here
In STEP Perspective, from Seattle Treatment Education Project
- The Effects of Club Drugs on HAART (December 2002)
To read PDF, click here
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Pharmacology and Drug Interactions: A Progress Report (September 2002)
A report from the International AIDS Conference.
In Hopkins HIV Report
- Drug Interactions: Ritonavir as PI Booster (July 2001)
From Project Inform
- Drug-Drug Interactions With HIV-Related Medications (2006)
A chapter from Clinical Manual for Management of the HIV-Infected Adult.
From AIDS Education & Training Centers National Resource Center
- Recreational Drugs and Antiretroviral Therapy (2006)
A chapter from Clinical Manual for Management of the HIV-Infected Adult.
From AIDS Education & Training Centers National Resource Center
Drug Interaction Research
- Drug Monitoring and Pharmacology: More Mixes Nixed By Concentration Preoccupations (August 2004)
Highlights from a CROI 2004 post-conference workshop on drug-drug interactions.
In TAGline, from Treatment Action Group
- Tipranavir Reduces Concentrations of Other Protease Inhibitors (July 14, 2004)
In The XV International AIDS Conference, from The Body PRO
- Tenofovir and Abacavir Do Not Interact in Patients on Triple-Nucleoside Regimens (July 13, 2004)
In The XV International AIDS Conference, from The Body PRO
- Making Right Turns in the HIV Pharmacology Maze: 5th International Workshop on Clinical Pharmacology of HIV Therapy (July 2004)
Highlighted research on host factor relevance, new antiretrovirals and drug-drug interactions.
To read PDF, click here
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Dosing Agenerase + Kaletra -- Trying to Juggle, Walk and Chew Gum All at the Same Time (March/April 2004)
A study presented at CROI 2004 bolsters support for the use of therapeutic drug monitoring to customize dosing.
In Positively Aware, from Test Positive Aware Network
- Efavirenz May Reduce Blood Levels of Cholesterol Drugs (March/April 2004)
A study presented at CROI 2004 suggests an interaction between efavirenz and simvastatin (Zocor) or atorvastatin (Lipitor).
In Positively Aware, from Test Positive Aware Network
- A Look at Tenofovir Drug-Drug Interactions (September 16, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- No PK Interaction Seen Between FTC and AZT or Tenofovir (September 16, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- Pharmacokinetic Interactions of 908 (September 16, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- No Interactions Between Tipranavir/Ritonavir and Efavirenz, Tenofovir and AZT (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
- HIV-Positive Man Dies of Kidney Failure and Lactic Acidosis Due to Tenofovir/ddI Interaction (April 8, 2003)
From aidsmap.com
- Didanosine and Tenofovir DF Drug-Drug Interaction: Assessment of Didanosine Dose Reduction (February 12, 2003)
In The 10th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Lack of Interaction Between Stavudine Extended-Release Formulation and Tenofovir Disoproxil Fumarate (February 12, 2003)
In The 10th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Pharmacokinetic Parameters of Atazanavir/Ritonavir When Combined to Tenofovir in HIV Infected Patients With Multiple Treatment Failures: A Substudy of Puzzle2-ANRS 107 Trial (February 12, 2003)
In The 10th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- New Questions About an Old Combination -- ddI + d4T (January 2003)
To read PDF, click here
In Project Inform Perspective, from Project Inform
- Tenofovir DF and Didanosine EC: Investigation of Pharmacokinetic Drug-Drug and Drug-Food Interactions (July 11, 2002)
In The XIV International AIDS Conference, from The Body PRO
- Polypharmacy Problems: Drug Interactions in the Multi-Drug Therapy of HIV Infection (February 6, 2002)
In The PRN Notebook
- Drug Interaction: Ritonavir and Fluticasone (November 2001)
Possible link found to Cushing's Syndrome.
In HIV Treatment ALERTS!, from The Center for AIDS
- Ingrown Toenails Still a Possible Side Effect (November 2001)
Indinavir-ritonavir interaction is possible culprit.
In HIV Treatment ALERTS!, from The Center for AIDS
- Lack of Clinically Relevant Drug-Drug Interactions Between Tenofovir DF and Efavirenz, Indinavir, Lamivudine and Lopinavir/Ritonavir in Healthy Subjects (October 29, 2001)
In 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, from The Body PRO
- Minor Interaction Between Efavirenz and Saquinavir When Combined With Small Doses of Ritonavir in a QD Regimen (October 28, 2001)
In 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, from The Body PRO
Drug-Drug Interaction Tools